11.03.2014 • News • Anthony Gerace • Mergers & Acquisitions (M&A) • Brenntag

Brenntag names Anthony Gerace to lead global Mergers & Acquisitions for Brenntag Group

Brenntag announces that Anthony Gerace will be promoted to Managing Director Mergers & Acquisitions for the Group, effective March 1, 2014.

In this new position Anthony Gerace will lead the Group's Mergers & Acquisitions team to focus on further expansion, in line with Brenntag's strategy. Anthony Gerace will report to Steven Holland, Chief Executive Officer.

Anthony Gerace joined Brenntag in 1993 and is currently responsible for Mergers & Acquisitions activities in the Brenntag North American organization. During his tenure with the company he has accumulated significant expertise in successfully managing operating companies in addition to directing strategic Mergers & Acquisitions projects for Brenntag in North America.

Brenntag Group's Chief Executive Officer Steven Holland: "I'm delighted to announce the appointment of Anthony Gerace as Managing Director Mergers & Acquisitions. He is singularly qualified for this role. As a knowledgeable professional in this field, he brings especially strong expertise in the Mergers & Acquisitions sphere and will support Brenntag's already successful track record in this important area." 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Top-Feature

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.